Disseminated infection due to Nocardia transvalensis coincident with Cryptococcus neoformans variety gattii meningitis

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 18, Issue 8, 1999, Pages 587-590

  Dyer, J R ^a,b   Ketheesan, N ^c   Norton, R E ^b   Ashhurst Smith, C I J ^b   Keary, P ^b   La Brooy, J T ^b,c  

^a St Andrew's Ipswich Private Hospital   (Australia)

^b TOWNSVILLE HOSPITAL   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPHOTERICIN B; CILASTATIN PLUS IMIPENEM; CIPROFLOXACIN; COTRIMOXAZOLE; FLUCONAZOLE; FLUCYTOSINE;

ADULT; ANTIMICROBIAL THERAPY; ARTICLE; CASE REPORT; CLUBBING FINGERS; CRYPTOCOCCUS NEOFORMANS; DROWSINESS; FEMALE; GAIT DISORDER; HEADACHE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKOCYTE COUNT; LUMBAR PUNCTURE; LYMPHOCYTE PROLIFERATION; MENINGITIS; NAUSEA; NOCARDIOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 0032710638     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s100960050352     Document Type: Article

References (15)

1. 1. Christoph I: Pulmonary Cryptococcus neoformans and disseminated Nocardia brasiliensis in an immunocompromised host. North Carolina Medical Journal (1990) 51:219-220
2. 2. Schreiner DT, de Castro P, Jorizzo JL, Soloman AR, Holder WR: Disseminated Nocardia brasiliensis infection following cryptococcal disease. Archives of Dermatology (1986) 122:1186-1190
3. 3. Buchanan KL, Murphy JW: What makes Cryptococcus neoformans a pathogen? Emerging Infectious Diseases (1998) 4:71-83
4. 4. Mitchell DH, Sorrell TC, Allworth AM, Heath CH, McGregor AR, Papanaoum K, Richards MJ, Gottlieb T: Cryptococcal disease of the CNS in immunocompetent hosts: influence of cryptococcal variety on clinical manifestations and outcome. Clinical Infectious Diseases (1995) 20:611-616
5. 5. Seaton RA, Naraqi S, Wembri JP, Warrell DA: Predictors of outcome in Cryptococcus neoformans var. gattii meningitis. Quarterly Journal of Medicine (1996) 89:423-428
6. 6. McNeil MM, Brown JM, Georghiou PR, Allworth AM, Blacklock ZM: Infection due to Nocardia transvalensis: clinical spectrum and antimicrobial therapy. Clinical Infectious Diseases (1992) 15:453-463
7. 7. Beaman BL, Beaman L: Nocardia species: host-parasite relationships. Clinical Microbiology Reviews (1994) 7:213-264
8. 8. Szabo G, Verma B, Catalano D: Selective inhibition of antigen-specific T lymphocyte proliferation by acute ethanol exposure: the role of impaired monocyte antigen presentation capacity and mediator production. Journal of Leukocyte Biology (1993) 54:534-544
9. 9. Romagnani S: The Th1/Th2 paradigm. Immunology Today (1997) 18:263-266
10. 10. Romani L: The T-cell response against fungal infections. Current Opinion in Immunology (1997) 9:484-490
11. 11. Pearlman E, Kazura JW, Hazlett FE Jr, Boom WH: Modulation of murine cytokine responses to mycobacterial antigens by helminth-induced T helper 2 cell responses. Journal of Immunology (1993) 151:4857-4864
12. 12. Dong ZM, Murphy JW: Effects of two varieties of Cryptococcus neoformans cells and culture filtrate antigens on neutrophil locomotion. Infection and Immunity (1995) 63:2632-2644
13. 13. Lipovsky MM, Gekker G, Hu S, Ehrlich LC, Hoepelman AIM, Peterson PK: Cryptococcal glucuronoxylomannan induces interleukin (IL)-8 production by microglia but inhibits neutrophil migration toward IL-8. Journal of Infectious Diseases (1998) 177:260-263
14. 14. Murray HW: Interferon-gamma and host antimicrobial defense: current and future clinical applications. American Journal of Medicine (1994) 97:459-467
15. 15. Clemons KV, Brummer E, Stevens DA: Cytokine treatment of central nervous system infection: efficacy of interleukin-12 alone and synergy with conventional antifungal therapy in experimental cryptococcosis. Antimicrobial Agents and Chemotherapy (1994) 38:460-464